To Evaluate the Renal Protective Effects and Safety of 'Fimasartan and Atorvastatin' or 'Fimasartan, Atorvastatin and Ezetimibe'.

Clinical trial NCT07685054 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07685054
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Essential Hypertension Primary Hypercholesterolemia

Start date: 2026-08-01
Primary completion: 2029-08-15
Enrollment: 12700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.